_id
691097eaccc777a4e85d5be4
Ticker
EPRX
Name
Eupraxia Pharmaceuticals Inc. Common Stock
Exchange
PINK
Address
2067 Cadboro Bay Road, Victoria, BC, Canada, V8R 5G4
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.eupraxiapharma.com
Description
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. The company's proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. Its lead product candidates include EP-104IAR, which is in Phase III clinical trial for the treatment of unmet medical needs and pain relief for knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Last Close
7.6474
Volume
144407
Current Price
7.6226
Change
0.02
Last Updated
2026-01-03T11:05:39.801Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
387864288
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.988
Sentiment Sources
1
Rating
4
Strong Buy
0
Buy
7
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
9577489
Operating Income
-9577489
Interest Expense
0
Pretax Income
-8863510
Net Income
-8851524
Eps
-0.23978116868398974
Dividends Per Share
-
Shares Outstanding
50648331
Income Tax Expense
-866.87
EBITDA
-8724730
Operating Margin
-
Total Other Income Expense Net
713979
Cash
123953229
Short Term Investments
-
Receivables
194937
Inventories
-
Total Current Assets
127178000
Property Plant Equipment
1184951
Total Assets
128499000
Payables
5196912
Short Term Debt
105939
Long Term Debt
-
Total Liabilities
5434808
Equity
125270000
Bs_currency_symbol
USD
Depreciation
62993
Change In Working Capital
1701116
Cash From Operations
-4506556
Capital Expenditures
60377
Cash From Investing
-60377
Cash From Financing
73897894
Net Change In Cash
69193637
Cf_currency_symbol
USD
PE
-
PB
2.2462548703073364
ROE
-7.065956733455736
ROA
-6.888399131510751
FCF
-4566933
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
4
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
9577489
Quarters > 0 > income Statement > operating Income
-9577489
Quarters > 0 > income Statement > interest Expense
0
Quarters > 0 > income Statement > pretax Income
-8863510
Quarters > 0 > income Statement > net Income
-8851524
Quarters > 0 > income Statement > eps
-0.23978116868398974
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
36915009
Quarters > 0 > income Statement > income Tax Expense
-866.87
Quarters > 0 > income Statement > EBITDA
-8724730
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
713979
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
123953229
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
194937
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
127178000
Quarters > 0 > balance Sheet > property Plant Equipment
1184951
Quarters > 0 > balance Sheet > total Assets
128499000
Quarters > 0 > balance Sheet > payables
5196912
Quarters > 0 > balance Sheet > short Term Debt
105939
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
5434808
Quarters > 0 > balance Sheet > equity
125270000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-6369358
Quarters > 0 > cash Flow > depreciation
62993
Quarters > 0 > cash Flow > change In Working Capital
1701116
Quarters > 0 > cash Flow > cash From Operations
-4506556
Quarters > 0 > cash Flow > capital Expenditures
60377
Quarters > 0 > cash Flow > cash From Investing
-60377
Quarters > 0 > cash Flow > cash From Financing
73897894
Quarters > 0 > cash Flow > net Change In Cash
69193637
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.23978116868398974
Quarters > 0 > ratios > PB
2.2462548703073364
Quarters > 0 > ratios > ROE
-7.065956733455736
Quarters > 0 > ratios > ROA
-6.888399131510751
Quarters > 0 > ratios > FCF
-4566933
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
11259256
Quarters > 1 > income Statement > operating Income
-11259256
Quarters > 1 > income Statement > interest Expense
0
Quarters > 1 > income Statement > pretax Income
-11910502
Quarters > 1 > income Statement > net Income
-11908886
Quarters > 1 > income Statement > eps
-0.3316095541778874
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
35912373
Quarters > 1 > income Statement > income Tax Expense
7603
Quarters > 1 > income Statement > EBITDA
-11834981
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-651245
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
19765644
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
134607
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
22829767
Quarters > 1 > balance Sheet > property Plant Equipment
688325
Quarters > 1 > balance Sheet > total Assets
23595934
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
35065
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2618381
Quarters > 1 > balance Sheet > equity
22554821
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-8747683
Quarters > 1 > cash Flow > depreciation
55431
Quarters > 1 > cash Flow > change In Working Capital
-1475825
Quarters > 1 > cash Flow > cash From Operations
-8315254
Quarters > 1 > cash Flow > capital Expenditures
166225
Quarters > 1 > cash Flow > cash From Investing
-166225
Quarters > 1 > cash Flow > cash From Financing
239778
Quarters > 1 > cash Flow > net Change In Cash
-7688954
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.3316095541778874
Quarters > 1 > ratios > PB
12.136902103093615
Quarters > 1 > ratios > ROE
-52.79973625150915
Quarters > 1 > ratios > ROA
-50.47007675135894
Quarters > 1 > ratios > FCF
-8481479
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
35
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
10145672
Quarters > 2 > income Statement > operating Income
-10145672
Quarters > 2 > income Statement > interest Expense
0
Quarters > 2 > income Statement > pretax Income
-9633365
Quarters > 2 > income Statement > net Income
-9630697
Quarters > 2 > income Statement > eps
-0.26987131964754163
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
35686256
Quarters > 2 > income Statement > income Tax Expense
3978
Quarters > 2 > income Statement > EBITDA
-9567162
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
512307
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
27454598
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
238531
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
28606412
Quarters > 2 > balance Sheet > property Plant Equipment
546537
Quarters > 2 > balance Sheet > total Assets
29233179
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
52774
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2199991
Quarters > 2 > balance Sheet > equity
28603689
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-6767275
Quarters > 2 > cash Flow > depreciation
46487
Quarters > 2 > cash Flow > change In Working Capital
-707399
Quarters > 2 > cash Flow > cash From Operations
-6003071
Quarters > 2 > cash Flow > capital Expenditures
169044
Quarters > 2 > cash Flow > cash From Investing
-169044
Quarters > 2 > cash Flow > cash From Financing
429923
Quarters > 2 > cash Flow > net Change In Cash
-5646696
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.26987131964754163
Quarters > 2 > ratios > PB
9.51003400245332
Quarters > 2 > ratios > ROE
-33.66942284961915
Quarters > 2 > ratios > ROA
-32.94440539634776
Quarters > 2 > ratios > FCF
-6172115
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
35
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
10759232
Quarters > 3 > income Statement > operating Income
-10759232
Quarters > 3 > income Statement > interest Expense
197.02
Quarters > 3 > income Statement > pretax Income
-10829591
Quarters > 3 > income Statement > net Income
-10798555
Quarters > 3 > income Statement > eps
-0.30313815520184645
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
35622553
Quarters > 3 > income Statement > income Tax Expense
2594
Quarters > 3 > income Statement > EBITDA
-10751000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-70358
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
33101294
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
228872
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
34436678
Quarters > 3 > balance Sheet > property Plant Equipment
424916
Quarters > 3 > balance Sheet > total Assets
34942355
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
71859
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3103386
Quarters > 3 > balance Sheet > equity
33404803
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-7532342
Quarters > 3 > cash Flow > depreciation
54512
Quarters > 3 > cash Flow > change In Working Capital
568715
Quarters > 3 > cash Flow > cash From Operations
-5972330
Quarters > 3 > cash Flow > capital Expenditures
44315
Quarters > 3 > cash Flow > cash From Investing
-43757
Quarters > 3 > cash Flow > cash From Financing
31731082
Quarters > 3 > cash Flow > net Change In Cash
24439498
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.30313815520184645
Quarters > 3 > ratios > PB
8.12866558434127
Quarters > 3 > ratios > ROE
-32.32635438682276
Quarters > 3 > ratios > ROA
-30.903913030475476
Quarters > 3 > ratios > FCF
-6016645
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
35
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
38833335
Annuals > 0 > income Statement > operating Income
-38833335
Annuals > 0 > income Statement > interest Expense
867992.3
Annuals > 0 > income Statement > pretax Income
-37020297
Annuals > 0 > income Statement > net Income
-36674941
Annuals > 0 > income Statement > eps
-1.0808818005589353
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
33930575
Annuals > 0 > income Statement > income Tax Expense
2594
Annuals > 0 > income Statement > EBITDA
-35905358
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1813037
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
33101294
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
228872
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
34436678
Annuals > 0 > balance Sheet > property Plant Equipment
424916
Annuals > 0 > balance Sheet > total Assets
34942355
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
71859
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3103386
Annuals > 0 > balance Sheet > equity
33404803
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-25744489
Annuals > 0 > cash Flow > depreciation
171719
Annuals > 0 > cash Flow > change In Working Capital
-6764689
Annuals > 0 > cash Flow > cash From Operations
-29994491
Annuals > 0 > cash Flow > capital Expenditures
104227
Annuals > 0 > cash Flow > cash From Investing
-75159
Annuals > 0 > cash Flow > cash From Financing
45784207
Annuals > 0 > cash Flow > net Change In Cash
13759538
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-1.0808818005589353
Annuals > 0 > ratios > PB
7.689147358540028
Annuals > 0 > ratios > ROE
-109.7894245926252
Annuals > 0 > ratios > ROA
-104.95841221921076
Annuals > 0 > ratios > FCF
-30098718
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
26
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
209911
Annuals > 1 > income Statement > gross Profit
-209911
Annuals > 1 > income Statement > operating Expenses
27847229
Annuals > 1 > income Statement > operating Income
-27847229
Annuals > 1 > income Statement > interest Expense
1170173
Annuals > 1 > income Statement > pretax Income
-28929583
Annuals > 1 > income Statement > net Income
-28220796
Annuals > 1 > income Statement > eps
-1.1687264094859144
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
24146623
Annuals > 1 > income Statement > income Tax Expense
36423
Annuals > 1 > income Statement > EBITDA
-27603883
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-1082354
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
19341756
Annuals > 1 > balance Sheet > short Term Investments
-6162283
Annuals > 1 > balance Sheet > receivables
190612
Annuals > 1 > balance Sheet > inventories
2
Annuals > 1 > balance Sheet > total Current Assets
19803078
Annuals > 1 > balance Sheet > property Plant Equipment
456247
Annuals > 1 > balance Sheet > total Assets
20266229
Annuals > 1 > balance Sheet > payables
-
Annuals > 1 > balance Sheet > short Term Debt
10452028
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
19373903
Annuals > 1 > balance Sheet > equity
2216207
Annuals > 1 > balance Sheet > currency_symbol
CAD
Annuals > 1 > cash Flow > net Income
-28966006
Annuals > 1 > cash Flow > depreciation
155527
Annuals > 1 > cash Flow > change In Working Capital
5351763
Annuals > 1 > cash Flow > cash From Operations
-20748619
Annuals > 1 > cash Flow > capital Expenditures
73377
Annuals > 1 > cash Flow > cash From Investing
-73377
Annuals > 1 > cash Flow > cash From Financing
21078966
Annuals > 1 > cash Flow > net Change In Cash
1078367
Annuals > 1 > cash Flow > currency_symbol
CAD
Annuals > 1 > ratios > PE
-1.1687264094859144
Annuals > 1 > ratios > PB
82.47872879654292
Annuals > 1 > ratios > ROE
-1273.3826758962498
Annuals > 1 > ratios > ROA
-139.25035585061235
Annuals > 1 > ratios > FCF
-20821996
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
8
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
193273
Annuals > 2 > income Statement > gross Profit
-193273
Annuals > 2 > income Statement > operating Expenses
17617452
Annuals > 2 > income Statement > operating Income
-17617452
Annuals > 2 > income Statement > interest Expense
982856
Annuals > 2 > income Statement > pretax Income
-18990764
Annuals > 2 > income Statement > net Income
-18489629
Annuals > 2 > income Statement > eps
-0.9587347910577338
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
19285447
Annuals > 2 > income Statement > income Tax Expense
930519
Annuals > 2 > income Statement > EBITDA
-17860014
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-1373312
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
24727715
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
89715
Annuals > 2 > balance Sheet > inventories
2
Annuals > 2 > balance Sheet > total Current Assets
25168586
Annuals > 2 > balance Sheet > property Plant Equipment
718608
Annuals > 2 > balance Sheet > total Assets
25890569
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
175771
Annuals > 2 > balance Sheet > long Term Debt
8804705
Annuals > 2 > balance Sheet > total Liabilities
16131495
Annuals > 2 > balance Sheet > equity
10542565
Annuals > 2 > balance Sheet > currency_symbol
CAD
Annuals > 2 > cash Flow > net Income
-18990764
Annuals > 2 > cash Flow > depreciation
147894
Annuals > 2 > cash Flow > change In Working Capital
1514571
Annuals > 2 > cash Flow > cash From Operations
-14395201
Annuals > 2 > cash Flow > capital Expenditures
235550
Annuals > 2 > cash Flow > cash From Investing
9834371
Annuals > 2 > cash Flow > cash From Financing
10801079
Annuals > 2 > cash Flow > net Change In Cash
5732854
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.9587347910577338
Annuals > 2 > ratios > PB
13.847752780276906
Annuals > 2 > ratios > ROE
-175.38074462903478
Annuals > 2 > ratios > ROA
-71.41453322250277
Annuals > 2 > ratios > FCF
-14630751
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
16
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
111529
Annuals > 3 > income Statement > gross Profit
-111529
Annuals > 3 > income Statement > operating Expenses
14648928
Annuals > 3 > income Statement > operating Income
-14648928
Annuals > 3 > income Statement > interest Expense
1016994
Annuals > 3 > income Statement > pretax Income
-18328772
Annuals > 3 > income Statement > net Income
-18030780
Annuals > 3 > income Statement > eps
-1.2659757579289448
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
14242595
Annuals > 3 > income Statement > income Tax Expense
-1343734
Annuals > 3 > income Statement > EBITDA
-17224305
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-3679843
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
20892069
Annuals > 3 > balance Sheet > short Term Investments
9008855
Annuals > 3 > balance Sheet > receivables
337028
Annuals > 3 > balance Sheet > inventories
1
Annuals > 3 > balance Sheet > total Current Assets
30601628
Annuals > 3 > balance Sheet > property Plant Equipment
589068
Annuals > 3 > balance Sheet > total Assets
31222067
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
154799
Annuals > 3 > balance Sheet > long Term Debt
7265448.39
Annuals > 3 > balance Sheet > total Liabilities
12104059
Annuals > 3 > balance Sheet > equity
19951843
Annuals > 3 > balance Sheet > currency_symbol
CAD
Annuals > 3 > cash Flow > net Income
-18175582
Annuals > 3 > cash Flow > depreciation
88174
Annuals > 3 > cash Flow > change In Working Capital
-167157
Annuals > 3 > cash Flow > cash From Operations
-11575672
Annuals > 3 > cash Flow > capital Expenditures
341278
Annuals > 3 > cash Flow > cash From Investing
-11424026
Annuals > 3 > cash Flow > cash From Financing
39462814
Annuals > 3 > cash Flow > net Change In Cash
16399431
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.2659757579289448
Annuals > 3 > ratios > PB
5.40383382878464
Annuals > 3 > ratios > ROE
-90.37150101872794
Annuals > 3 > ratios > ROA
-57.75011628794468
Annuals > 3 > ratios > FCF
-11916950
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
25
Valuation > metrics > PE
-0.23978116868398974
Valuation > metrics > PB
2.2462548703073364
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-7.065956733455736
Profitability > metrics > ROA
-6.959949047791285
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.043384752933663284
Risk > metrics > Interest Coverage
-69.01202622856319
Risk > final Score
-216
Risk > verdict
High
Liquidity > metrics > Current Ratio
23.98294804059175
Liquidity > metrics > Quick Ratio
23.98294804059175
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
20
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-536
Prev Risks > 1
-553
Prev Risks > 2
-218379
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:47:19.028Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-31
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.1435
Earnings History > 0 > eps Difference
0.1435
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-04
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.19
Earnings History > 1 > eps Estimate
-0.1755
Earnings History > 1 > eps Difference
-0.0145
Earnings History > 1 > surprise Percent
-8.2621
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-12
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.2419
Earnings History > 2 > eps Estimate
-0.1804
Earnings History > 2 > eps Difference
-0.0615
Earnings History > 2 > surprise Percent
-34.0909
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-06-06
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
CAD
Earnings History > 3 > eps Actual
-0.21
Earnings History > 3 > eps Estimate
-0.1667
Earnings History > 3 > eps Difference
-0.0433
Earnings History > 3 > surprise Percent
-25.9748
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-20
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.2104
Earnings History > 4 > eps Estimate
-0.1247
Earnings History > 4 > eps Difference
-0.0857
Earnings History > 4 > surprise Percent
-68.7249
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-07
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.1212
Earnings History > 5 > eps Estimate
-0.13
Earnings History > 5 > eps Difference
0.0088
Earnings History > 5 > surprise Percent
6.7692
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-06-30
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-
Earnings History > 6 > eps Estimate
-0.17
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-03-31
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-
Earnings History > 7 > eps Estimate
-0.17
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. The company's proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. Its lead product candidates include EP-104IAR, which is in Phase III clinical trial for the treatment of unmet medical needs and pain relief for knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of other inflammatory joint conditions, benign structures of the esophagus, and epidural delivery. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIdeas Watch: Is TXO Partners LP in a long term uptrend - Stop Loss & AI Enhanced Market Trend Forecasts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
7
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Eupraxia Pharmaceuticals Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.1435
Date
2025-09-30
EPS Actual
-0.19
EPS Estimate
-0.1755
EPS Difference
-0.0145
Surprise Percent
-8.2621%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.